Autoimmunity Reviews

Article	Citations
Editorial Board	247
Editorial Board	176
“Fibromyalgia syndrome” related to Essure devices	150
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	140
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	139
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	94
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	94
Editorial Board	91
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	87
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	87
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	84
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	76
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	73
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	71
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	70
Susac syndrome: A scoping review	67
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	65
Editorial Board	63
Endometriosis and autoimmunity	63
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	62
Can anticoagulation be withdrawn in APS patients after aPL negativization?	62
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	62
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	61
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	59
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	58

Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	57
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	56
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	56
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	54
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	54
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	51
Seronegative autoimmune diseases: A challenging diagnosis	50
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	48
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	47
Autoimmunity in vitiligo: Therapeutic implications and opportunities	47
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	45
Psychiatric manifestations of autoimmune encephalitis	45
Autoimmune pre-disease	44
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	44
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	44
Cardiovascular outcome in adult-onset Kawasaki disease	43
A descriptive study of IgG4-related disease in children and young adults	42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	41
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	41
Editorial Board	41
SpA plus IBD or IBD plus SpA: Does commutative property apply?	40
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	40
Adipose failure through adipocyte overload and autoimmunity	39
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	38
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	38
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	38
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	37
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	37
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	37
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	36
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	35
Histopathological features of systemic sclerosis-associated myopathy: A scoping review	35
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	35
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	34
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	34
Editorial Board	34
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	33
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	33
Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19	33
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	33
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	31
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	30
Development of an algorithm for IgG4-related disease management	29
Fibromyalgia: Are we using the biopsychosocial model?	28
Tumor necrosis factor-α inhibitor-related autoimmune disorders	28
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	28
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	28
The role of mitochondrial dysfunction in kidney injury and disease	28
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	28

Editorial Board	27
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	27
Are IF-ANA the guiding light for SLE classification in the real-world setting?	27
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	27
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	27
Reply letter to letter to the editor	27
Editorial Board	26
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	26
Twenty shades of the mosaic of autoimmunity	26
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	26
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	26
Editorial Board	26
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	25
Alarmins in autoimmune diseases	25
Rheumatological complications of Covid 19	25
Tumors, tumor therapies, autoimmunity and the eye	25
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	25
In Memoriam: Pierre Youinou	24
Neuroimaging in thyroid eye disease: A systematic review	24
Mucous membrane pemphigoid	24
Editorial Board	24
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	24
Reactive oxygen species: The Yin and Yang in (auto-)immunity	23
Cutting edge confusion about cut-off settings in autoimmune diagnostics	23
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	23
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	23
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics	23
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	23
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	23
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	22
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	22
Serum calprotectin is a marker of disease activity in Giant cell arteritis	21
Is it time for treat-to-target in antiphospholipid syndrome?	21
Salivary gland involvement in ANCA-associated vasculitis	21
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	21
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	21
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	21
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	21
Editorial Board	21
Diagnostic approach in giant cell arteritis	21
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	21
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	20
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	20
JAK inhibitors and systemic sclerosis: A systematic review of the literature	20
Persistent aortic inflammation in patients with giant cell arteritis	20
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	20
From inflammation to renal fibrosis: A one-way road in autoimmunity?	20
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	20
Inflammatory muscle involvement in systemic vasculitis: A systematic review	20
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	19
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	19
Editorial Board	19
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	19
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	19
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	19
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	18
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	18
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent	18
Don't mix apples and oranges. Reply to Azoulay et al.	18
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	18
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	18
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	18
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	17
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases	17
Intermittent fasting: A promising dietary intervention for autoimmune diseases	17
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	17
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	17
Autoimmunity and COVID-19 – The microbiotal connection	17
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	17
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	17
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	17
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	17
Scleroderma specific autoantibodies and MS-like manifestations: A novel association?	17
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	16
Involvement of aquaporin 5 in Sjögren’s syndrome	16
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	16
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	16
Emerging roles of mechanically activated ion channels in autoimmune disease	16

Anti-glomerular basement membrane vasculitis	16
Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?	16
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	16
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	16
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	16
Editorial Board	15
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	15
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	15
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	15
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	15
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	15
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	15
Prevention of rheumatoid arthritis using a familial predictive medicine approach	15
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	15
Editorial Board	15
Insights into new-onset autoimmune diseases after COVID-19 vaccination	15
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	15
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	15
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	14
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	14
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	14
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	14
Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review	14
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	14
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	13
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	13
Relapses in giant cell arteritis: Updated review for clinical practice	13
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation	13
Intravenous immunoglobulin as a therapy for autoimmune conditions	13
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	13
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	13
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	13
Gut microbiota–microRNA interactions in ankylosing spondylitis	13
Editorial Board	13
Prenatal and perinatal factors associated with developing multiple sclerosis later in life: A systematic review and meta-analysis	13
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	13
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	13
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	13
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	13
Editorial Board	12
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	12
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	12
Editorial Board	12
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	12
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	12
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	12
A new challenge for lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen	12
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	12
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	12
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	11
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	11
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	11
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases	11
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	11
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	11
ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature	11
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials	11
Building a monitoring matrix for the management of multiple sclerosis	10
Residual pain in rheumatoid arthritis: Is it a real problem?	10
Exposome: Epigenetics and autoimmune diseases	10
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	10
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	10
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	10
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	10
Circadian clock genes as promising therapeutic targets for autoimmune diseases	10
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	10
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	10
Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis	10
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	10
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	10
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	10
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	10
Editorial Board	9
Editorial Board	9
Aquaporins: Unexpected actors in autoimmune diseases	9
SLE patients with childhood-onset: A nation-wide population-based study	9
Renal involvement in systemic sclerosis	9
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	9
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases	9
Editorial Board	9
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	9
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	9
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	9
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	9
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	9
Editorial Board	9
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	9
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	9
Key points to consider for an improved detection and characterization of cryoglobulins	9
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	9
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	9
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?	8
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach	8
Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review	8
T cell abnormalities in systemic sclerosis	8